Related Experiment Video
Updated: Aug 11, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death
Maria Castedo1,2, Antoine Lafarge1,2,3, Guido Kroemer1,2,4
1Equipe 11 labellisée par la Ligue contre le Cancer, Université de Paris Cité, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, 75006 Paris, France.
Abstract:
The deletion of the gene coding for poly(ADP-ribose) polymerase-1 (PARP1) or its pharmacological inhibition protects mice against cerebral ischemia and Parkinson's disease. In sharp contrast, PARP1 inhibitors are in clinical use for the eradication of vulnerable cancer cells. It appears that excessive PARP1 activation is involved in a specific cell death pathway called parthanatos, while inhibition of PARP1 in cancer cells amplifies DNA damage to a lethal level. Hence, PARP1 plays a context-dependent role in cell fate decisions. In addition, it appears that PARP1 plays an ambiguous role in organismal aging.
Insights
Poly(ADP-ribose) polymerase-1 (PARP1) inhibition shows protective effects against neurological diseases but aids cancer cell death. PARP1
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Poly(ADP-ribose) polymerase-1 (PARP1) is implicated in DNA repair and cell death pathways.
- PARP1 activity has been linked to neuroprotection in models of cerebral ischemia and Parkinson's disease.
- PARP1 inhibitors are utilized in cancer therapy to induce cell death.
Purpose of the Study:
- To elucidate the context-dependent role of PARP1 in cell fate.
- To investigate the dual role of PARP1 in neurological protection and cancer therapy.
- To explore the ambiguous involvement of PARP1 in organismal aging.
Main Methods:
- Gene deletion studies in mice.
- Pharmacological inhibition of PARP1.
- Analysis of cell death pathways, including parthanatos.
- Assessment of DNA damage response in cancer cells.
Main Results:
- PARP1 deletion or inhibition protects against cerebral ischemia and Parkinson's disease in mice.
- PARP1 inhibition in cancer cells leads to amplified DNA damage and cell death.
- Excessive PARP1 activation is associated with parthanatos, a specific cell death pathway.
Conclusions:
- PARP1 plays a critical, context-dependent role in determining cell fate.
- PARP1 inhibition offers therapeutic potential in both neurological disorders and cancer, albeit through different mechanisms.
- The role of PARP1 in aging requires further investigation due to its ambiguous nature.
Related Concept Videos
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Biosynthesis of Nucleic Acids
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

